Acute Porphyria Drugs

D07XC03 - Mometasone

Not porphyrinogenic
NP

Rationale
The glucocorticoid is stated in several references not to be porphyrinogenic. Probably only insignificant systemic exposure.
Chemical description
Strong glucocorticoid salve, momethasone 0.001%, used in severe plaque psoriasis. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe. .
Similar drugs
Explore alternative drugs in similar therapeutic classes D07X / D07XC or go back.
References
# Citation details PubMed ID
1. Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
9554242
2. Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
9074793
Other sources
3. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Elocom Plus Elosalic Derma q · Inflamed · Losalen Elosalic Elosalic · Momate · Momesalic · Momoz Elosalic
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙